Vanguard Group’s Biomerica BMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $53.2K | Hold |
21,127
| – | – | ﹤0.01% | 4240 |
|
|
2025
Q3 | $59.8K | Hold |
21,127
| – | – | ﹤0.01% | 4280 |
|
|
2025
Q2 | $66.8K | Buy |
21,127
+1
| +0% | +$4 | ﹤0.01% | 4173 |
|
|
2025
Q1 | $95.8K | Hold |
21,126
| – | – | ﹤0.01% | 4144 |
|
|
2024
Q4 | $50.7K | Hold |
21,126
| – | – | ﹤0.01% | 4213 |
|
|
2024
Q3 | $55.4K | Sell |
21,126
-5,706
| -21% | -$16.3K | ﹤0.01% | 4238 |
|
|
2024
Q2 | $94.4K | Sell |
26,832
-49,339
| -65% | -$251K | ﹤0.01% | 4236 |
|
|
2024
Q1 | $507K | Hold |
76,171
| – | – | ﹤0.01% | 4006 |
|
|
2023
Q4 | $762K | Buy |
76,171
+5,354
| +8% | +$40.5K | ﹤0.01% | 3911 |
|
|
2023
Q3 | $487K | Sell |
70,817
-428
| -0.6% | -$4.24K | ﹤0.01% | 4058 |
|
|
2023
Q2 | $775K | Hold |
71,245
| – | – | ﹤0.01% | 3976 |
|
|
2023
Q1 | $1.07M | Buy |
71,245
+2,975
| +4% | +$64.1K | ﹤0.01% | 3893 |
|
|
2022
Q4 | $1.83M | Buy |
68,270
+26
| +0% | +$747 | ﹤0.01% | 3691 |
|
|
2022
Q3 | $2.15M | Hold |
68,244
| – | – | ﹤0.01% | 3707 |
|
|
2022
Q2 | $1.58M | Hold |
68,244
| – | – | ﹤0.01% | 3912 |
|
|
2022
Q1 | $2.44M | Hold |
68,244
| – | – | ﹤0.01% | 3880 |
|
|
2021
Q4 | $2.12M | Sell |
68,244
-4,395
| -6% | -$169K | ﹤0.01% | 4012 |
|
|
2021
Q3 | $2.62M | Hold |
72,639
| – | – | ﹤0.01% | 3976 |
|
|
2021
Q2 | $2.33M | Sell |
72,639
-2,440
| -3% | -$82.7K | ﹤0.01% | 3930 |
|
|
2021
Q1 | $3.28M | Buy |
75,079
+4,116
| +6% | +$211K | ﹤0.01% | 3724 |
|
|
2020
Q4 | $2.83M | Sell |
70,963
-6,170
| -8% | -$309K | ﹤0.01% | 3567 |
|
|
2020
Q3 | $4.28M | Buy |
77,133
+1,207
| +2% | +$78K | ﹤0.01% | 3231 |
|
|
2020
Q2 | $4.4M | Buy |
75,926
+39,202
| +107% | +$2.2M | ﹤0.01% | 3152 |
|
|
2020
Q1 | $2.1M | Buy |
36,724
+20,946
| +133% | +$639K | ﹤0.01% | 3295 |
|
|
2019
Q4 | $375K | Hold |
15,778
| – | – | ﹤0.01% | 3849 |
|
|
2019
Q3 | $410K | Buy |
15,778
+13,698
| +659% | +$332K | ﹤0.01% | 3857 |
|
|
2019
Q2 | $43K | Hold |
2,080
| – | – | ﹤0.01% | 4120 |
|
|
2019
Q1 | $41K | Hold |
2,080
| – | – | ﹤0.01% | 4071 |
|
|
2018
Q4 | $28K | Sell |
2,080
-9,566
| -82% | -$215K | ﹤0.01% | 4107 |
|
|
2018
Q3 | $334K | Buy |
11,646
+37
| +0.3% | +$1.11K | ﹤0.01% | 3921 |
|
|
2018
Q2 | $361K | Buy |
11,609
+170
| +1% | +$5.16K | ﹤0.01% | 3880 |
|
|
2018
Q1 | $370K | Buy |
11,439
+1,484
| +15% | +$50.9K | ﹤0.01% | 3843 |
|
|
2017
Q4 | $300K | Buy |
+9,955
| New | +$265K | ﹤0.01% | 3858 |
|
Other funds holding BMRA
DS
NA
HCM
HI
Vanguard Group's BMRA Position: Q4 2025 in Review
Vanguard Group held its Biomerica (BMRA) position steady in Q4 2025 at 21,127 shares worth $53.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4240.
Vanguard Group first reported a position in BMRA in Q4 2017 and has held it in 33 quarters since. The position peaked at $4.4M in Q2 2020. 13 funds tracked by Wall St. Rank hold BMRA as of Q4 2025.
- Vanguard Group held 21,127 shares of Biomerica worth $53.2K as of Q4 2025.
- Vanguard Group left its Biomerica share count unchanged in Q4 2025.
- Biomerica made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4240 holding.
- Vanguard Group first reported a position in Biomerica in Q4 2017 and has held it in 33 quarters since.
- Vanguard Group's Biomerica position peaked at $4.4M in Q2 2020.
- 13 funds tracked by Wall St. Rank held Biomerica as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.